Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, November 8, 2024

Early transcriptional changes in neutrophil-mediated processes following recanalization after ischemic stroke

I don't know what you were trying to do but boy, you know nothing!

 Early transcriptional changes in neutrophil-mediated processes following recanalization after ischemic stroke

Truong An Bui, Yonglie Ma, Glen C Jickling, Ian R Winship

Background: 

 Ischemic stroke is a leading cause of mortality and long-term disability globally. Current recanalization therapies, including mechanical thrombectomy and thrombolysis, aim to restore blood flow in acute ischemic stroke patients. However, many patients with successful recanalization still experience poor clinical outcomes. This phenomenon, where the restoration of blood flow does not translate into functional recovery, is known as futile recanalization. (Wow, you know nothing of the neuronal cascade of death, the recanalization worked, it's just that by not stopping the neuronal cascade of death in the first week, you are letting hundreds of millions to billions of neurons to die! For that incredible stupidity you all deserve to be fired!)

Methods: 

Using a murine middle cerebral occlusion (MCAO) model that mimics a large vessel occlusion with recanalization, a comprehensive microarray analysis of gene expression from blood samples collected during MCAO and after recanalization (N=44) was performed. Results: Il1r2, Cd55, Mmp8, Cd14, and Cd69 were key regulatory genes expressed early after MCAO and recanalization. A comparison with gene expression data from human stroke patients and rat MCAO model (GSE16561 and GSE21136) revealed Vcan as a differentially expressed gene conserved across species, marking it as a novel indicator of recanalization that was detected as early as 3 hours post-recanalization (4 hours post-MCAO) in mice and 24 hours after recanalization in rats (MCAO-thrombectomy) and humans (rtPA-thrombolysis). Leukocyte and neutrophil activation pathways were significantly enriched in the mouse data and human samples from GSE16561, with greater upregulation in female subjects. The analysis identified key miRNAs regulating gene expression in response to recanalization, and NFE4 and MTF1 as crucial transcription factors regulating these processes. Based on these data, a coregulatory network underlying neutrophil activity was constructed, highlighting its central role in early recanalization responses, especially in females. 

 Conclusions: 

This study identified new genomic markers in blood associated with recanalization, and identified critical age- and sex-specific factors. By mapping a coregulatory network of interacting genes and neutrophil-related pathways, the data provides insights to inform future research and develop targeted therapies. Such therapies can improve recanalization efficacy or modulate leukocytes to reduce futile recanalization, ultimately enhancing clinical outcomes for ischemic stroke patients.
Ischemic StrokeGene Expression
Neurology

No comments:

Post a Comment